Interleukin-1 family cytokines and mast cells: activation and inhibition

J Biol Regul Homeost Agents. 2019;33(1):1-6.

Abstract

Activated mast cells (MCs) secrete a number of compounds including pro-inflammatory and anti-inflammatory cytokines. MCs are a potential source of cytokines and chemokines which participate in allergic reactions and inflammation. MCs can be activated by IgE through its receptor FceRI, but also by Toll-like receptors and/or interleukin (IL)-1. MCs can be a target for both pro-inflammatory and anti-inflammatory cytokines. IL-1 activates MCs to release inflammatory chemical mediators, and cytokines/chemokines, an effect which can be potentially inhibited by IL-37. In addition, IL-36 is also a powerful cytokine with a pro-inflammatory activity. IL-38 binds IL-36R and inhibits the pro-inflammatory activity of IL-36, thus performing a therapeutic action. In this article we review the role of MCs in relation to pro-inflammatory and anti-inflammatory IL-1 family member cytokines and a possible therapeutic effect in inflammatory disorders.

Publication types

  • Editorial

MeSH terms

  • Chemokines / immunology
  • Cytokines / immunology*
  • Humans
  • Inflammation / immunology
  • Interleukin-1 / immunology*
  • Interleukins / immunology
  • Mast Cells / immunology*

Substances

  • Chemokines
  • Cytokines
  • IL-38 protein, human
  • IL36A protein, human
  • IL37 protein, human
  • Interleukin-1
  • Interleukins